Mankind Pharma Ltd.

NSE: MANKIND | BSE: 543904 | ISIN: INE634S01028 | Industry: Pharmaceuticals
| Expensive Performer
2547.3000 47.30 (1.89%)
NSE May 13, 2025 15:31 PM
Volume: 401.7K
 

2547.30
1.89%
Motilal Oswal
MANKIND has a strategic roadmap for growth through expansion in high entry barrier innovative product launches in the chronic/consumer segment and other adjacencies, transitioning from sexual wellness to consumer wellness in the over-the counter (OTC) space.
Number of FII/FPI investors increased from 624 to 640 in Mar 2025 qtr.
More from Mankind Pharma Ltd.
Recommended